Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions-Reference-Cited by-同舟云学术

Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions

Published:2019-07-31 Issue:7 Volume:14 Page:e0219521
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bennett Charles L.^ORCID,Schooley Benjamin,Taylor Matthew A.^ORCID,Witherspoon Bartlett J.^ORCID,Godwin Ashley,Vemula Jayanth,Ausdenmoore Henry C.,Sartor Oliver,Yang Y. Tony,Armitage James O.,Hrushesky William J.,Restaino John,Thomsen Henrik S.,Yarnold Paul R.,Young Terence,Knopf Kevin B.,Chen Brian^ORCID

Funder

American Cancer Society

National Cancer Institute

American Cancer Society (US)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Pharmacovigilance in oncology: evaluation of current practice and future perspectives;P Baldo;J Eval Clin Pract,2014

2. Toxicity and costs of toxicity associated with new cancer drugs: international implications;T Hermanson;J Clin Oncol,2014

3. Systematic Approach to Pharmacovigilance beyond the Limits: The Southern Network on Adverse Reactions (SONAR) Projects;KZ Lu;Adv Pharmacoepidemiol Drug Saf,2014

4. Evaluation of Serious Adverse Drug Reactions;CL Bennett;Arch Intern Med,2007

5. Thalidomide- and Lenalidomide-Associated Thromboembolism Among Patients With Cancer;CL Bennett;JAMA,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Davids versus Goliaths: Pharma and academia threats to individual scientists and clinicians;The Journal of Scientific Practice and Integrity;2022-06-24

2. Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997–2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR);Cancer Drug Safety and Public Health Policy;2022

3. Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR);EClinicalMedicine;2021-01

4. Response to: letter to the editor: consideration on ‘an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and drug administration and the European medicines agency’ by bennett et al;Expert Opinion on Drug Safety;2020-08-02

5. Pharmacovigilance of anti-cancer medicines: opportunities and challenges;Expert Opinion on Drug Safety;2020-06-18